Fuad El-hibri - Net Worth and Insider Trading
Fuad El-hibri Net Worth
The estimated net worth of Fuad El-hibri is at least $47 Million dollars as of 2025-01-19. Fuad El-hibri is the Chairman, 10% Owner of Emergent BioSolutions Inc and owns about 4,788,606 shares of Emergent BioSolutions Inc (EBS) stock worth over $47 Million. Fuad El-hibri is also the Director of Aptevo Therapeutics Inc and owns about 178 shares of Aptevo Therapeutics Inc (APVO) stock worth over $794. Details can be seen in Fuad El-hibri's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fuad El-hibri has not made any transactions after 2020-11-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Fuad El-hibri
Fuad El-hibri Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fuad El-hibri owns 2 companies in total, including Emergent BioSolutions Inc (EBS) , and Aptevo Therapeutics Inc (APVO) .
Click here to see the complete history of Fuad El-hibri’s form 4 insider trades.
Insider Ownership Summary of Fuad El-hibri
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EBS | Emergent BioSolutions Inc | 2020-11-10 | director & 10 percent owner & Chairman |
| APVO | Aptevo Therapeutics Inc | 2019-08-12 | director |
Fuad El-hibri Latest Holdings Summary
Fuad El-hibri currently owns a total of 2 stocks. Among these stocks, Fuad El-hibri owns 4,788,606 shares of Emergent BioSolutions Inc (EBS) as of November 10, 2020, with a value of $47 Million and a weighting of 100%. Fuad El-hibri also owns 178 shares of Aptevo Therapeutics Inc (APVO) as of August 12, 2019, with a value of $794 and a weighting of 0%.
Latest Holdings of Fuad El-hibri
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc | 2020-11-10 | 4,788,606 | 9.88 | 47,311,427 |
| APVO | Aptevo Therapeutics Inc | 2019-08-12 | 178 | 4.46 | 794 |
Holding Weightings of Fuad El-hibri
Fuad El-hibri Form 4 Trading Tracker
According to the SEC Form 4 filings, Fuad El-hibri has made a total of 16 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Emergent BioSolutions Inc is the sale of 39,391 shares on November 10, 2020, which brought Fuad El-hibri around $4 Million.
According to the SEC Form 4 filings, Fuad El-hibri has made a total of 0 transactions in Aptevo Therapeutics Inc (APVO) over the past 5 years. The most-recent trade in Aptevo Therapeutics Inc is the acquisition of 4 shares on August 12, 2019, which cost Fuad El-hibri around $76,000.
Insider Trading History of Fuad El-hibri
- 1
Fuad El-hibri Trading Performance
GuruFocus tracks the stock performance after each of Fuad El-hibri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fuad El-hibri is -26.86%. GuruFocus also compares Fuad El-hibri's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fuad El-hibri within 3 months outperforms 0 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Fuad El-hibri's insider trading performs compared to the benchmark.
Performance of Fuad El-hibri
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.5 | | | | | |
| Relative Return to S&P 500(%) | -7.13 | | | | | |
Fuad El-hibri Ownership Network
Ownership Network List of Fuad El-hibri
Ownership Network Relation of Fuad El-hibri
Fuad El-hibri Owned Company Details
What does Emergent BioSolutions Inc do?
Who are the key executives at Emergent BioSolutions Inc?
Fuad El-hibri is the director & 10 percent owner & Chairman of Emergent BioSolutions Inc. Other key executives at Emergent BioSolutions Inc include SVP & Bioservices William Hartzel , Interim CEO Miller H Haywood Iii , and SVP & Products Business Paul Anthony Williams .
Emergent BioSolutions Inc (EBS) Insider Trades Summary
Over the past 18 months, Fuad El-hibri made no insider transaction in Emergent BioSolutions Inc (EBS). Other recent insider transactions involving Emergent BioSolutions Inc (EBS) include a net sale of 12,919 shares made by Kathryn C Zoon , a net sale of 25,000 shares made by Donald W Degolyer , and a net sale of 14,287 shares made by Marvin L White .
In summary, during the past 3 months, insiders sold 39,287 shares of Emergent BioSolutions Inc (EBS) in total and bought 0 shares, with a net sale of 39,287 shares. During the past 18 months, 52,206 shares of Emergent BioSolutions Inc (EBS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 52,206 shares.
Emergent BioSolutions Inc (EBS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Emergent BioSolutions Inc Insider Transactions
Fuad El-hibri Mailing Address
Above is the net worth, insider trading, and ownership report for Fuad El-hibri. You might contact Fuad El-hibri via mailing address: 2273 Research Blvd, Suite 400, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
